Latest Tositumomab Stories
In a Breaking News Exclusive, Jamie Reno writes how GSK's spokesperson informed him that Bexxar, a lifesaving cancer drug is being discontinued in February 2014.
Long-term Results in both First-line and Refractory Settings Seen in Patients with Non-Hodgkin's Lymphoma PHILADELPHIA, Dec.
SAN FRANCISCO, Oct. 12 /PRNewswire/ -- Takeda San Francisco, Inc. announced today that Michael Buckley, Ph.D., has joined the company as vice president of process sciences. Dr.
PHILADELPHIA, July 29 /PRNewswire-USNewswire/ -- Diagnosed with lymphoma, a deadly cancer of the lymphatic system, award-winning Newsweek journalist Jamie Reno felt stunned and alone. What gave him hope was learning of others' successful battles with the disease.
NEW YORK (Reuters Health) - New treatments incorporating immunotherapy - strategies that boost the immune system -- have significantly improved overall survival of patients with a blood cancer called follicular lymphoma, according to a new report.
Researchers from the United States, France and Germany make advances, provide alternatives to traditional chemotherapy treatment.
- A poem in which the author retracts something said in an earlier poem.